Last Update: 15th Jan 2018
Conference Participation
Upcoming | Past Speaker | Poster Presentations
Upcoming, confirmed:
Lorne Cancer 2018
February 2018
Lorne, Victoria, Australia
Invited Speaker
More info
Hunter Cell Signalling Meeting 2018
March 2018
Hunter Valley, NSW, Australia
Invited Speaker
QMB Shanghai Meeting 2018
March 2018
Shanghai, China
Invited Speaker
Past speaker:
2017
29. 9th Auckland Mechano- and Matrix Biology Symposium
November 2017
Auskland, New Zealand
Invited Speaker
“Studying the dynamic ECM landscape in cancer”
28. 8th Barossa Cell Signalling Meeting
November 2017
Barossa Valley, SA, Australia
Speaker selected from abstract
“Studying the dynamic ECM landscape in cancer”
27. Danish Cancer Society Symposium 2017 – “Metastasis as a systemic disease“
October 2017
Copenhagen, Denmark
Invited Speaker
“The dynamic ECM landscape in cancer”
26. 25th Annual Silver Anniversary St Vincent’s Health Australia Symposium
September 2017
Sydney, Australia
Speaker selected from abstract
“The dynamic ECM landscape in cancer”
25. Queenstown Research Week – Molecular Biology Meeting
September 2017
Queenstown, New Zealand
Invited Speaker
“Remodelling of the ECM in cancer”
24. Sydney Catalyst 6th Post Graduate and Early Career Researcher Symposium
April 2017
Sydney, Australia
Keynote Speaker
23. British Society for Matrix Biology (BSMB) Spring Meeting – “Matrix Proteoglycans”
April 2017
Oxford, UK
Speaker selected from abstract
“Visualising ECM Remodelling in Cancer: ISDoT – In Situ Decellularisation of Tissues”
More info
22. Cancer Network Zurich – Cancer Biology Symposium 2017
March 2017
Zurich, Switzerland
Invited Speaker
“ECM Remodelling in Cancer: Implications for metastatic organotropism”
2016
21. Matrix Biology of Australia and New Zealand (MBSANZ)
November 2016
University of Sydney Camden Campus, Australia
Invited Speaker
“ECM Remodelling in Tumour Progression and Metastasis”
More info
20. 8th Garvan Signalling Symposium 2016
Oct – Nov 2016
Sydney, Australia
Invited Speaker
“ECM Remodelling in Tumour Progression and Metastasis”
More Info
19. Metastasis Research Society (MRS) 16th Biennial meeting
Chengdu, China
August 2016
Invited Short Talk, Session Chair
“Cancer: Opening LOX to Metastasis – The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase”
18. British Society for Matrix Biology (BSMB) Autumn Meeting – “The Art of Communication – Signalling cascades in mechanotransduction”
Cardiff, Wales, UK
August 2016
Young Investigator John Scott Award Plenary Lecture
“Fibrosis, Cancer and the Pre-Metastatic Niche:Implications for Lysyl Oxidases in Cancer Progression and Metastasis”
More info
17. Amine Oxidase Biennial Meeting 2016
Birmingham, United Kingdom
July 2016
Invited Speaker
“Lysyl oxidases in cancer progression and metastasis”
16. AACR Annual Conference 2016 (#AACR16)
New Orleans, LA, United States
April 2016
Invited Speaker, Major Symposia
“ECM Remodeling at the Pre-metastatic Niche: Implications for Lysyl Oxidase in Metastasis Organotropism”
More info
2015
15. CNIO Frontiers Meeting on “Metastasis Initiation: Mechanistic Insights and Therapeutic Opportunities”
Madrid, Spain
September 2015
Speaker selected from abstract
“Cancer – Opening LOX to metastasis: The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase”
More info
2014
14. Metastasis Research Society (MRS) 15th Biennial Congress
Heidelberg, Germany
Young Investigator Keynote Speaker, Session Chair
“Fibrosis, Cancer and the Pre-Metastatic Niche: Implications for Lysyl Oxidase”
More info
13. British Society for Matrix Biology (BSMB): “Building the extracellular matrix: Molecules, Cells and Evolution“
Bristol, United Kingdom
Speaker selected from abstract
“Pre-Metastatic bone lesions in breast cancer: Implications for Lysyl Oxidase”
12. ICCMSE 2014: “Functional diversity of LOX and LOX-like proteins”
Athens, Greece
Invited Speaker
“Lysyl Oxidases in Metastasis“
2013
11. International Conference on Systems Biology (ICSB)
Copenhagen, Denmark
Speaker selected from abstract
“Deep proteomic analysis of the hypoxic secretome reveals lysyl oxidase as a critical mediator of pre-metastatic bone lesions in breast cancer”
10. Biotech Research & Innovation Centre 10 year Symposium on “Cancer Biology“
Copenhagen, Denmark
Speaker selected from abstract
“The Hypoxic Secretome Reveals Lysyl Oxidase as a critical mediator of pre-metastatic bone lesions in breast cancer”
9. Gordon Research Conference (GRC) on “Collagen: In the Context of Matrix, Cells and Regenerative Medicine“
New London, NH, United States
Invited Speaker
“Lysyl Oxidases in Cancer Progression”
8. 5th MaxQuant Summer School on Computational Mass Spectrometry Based Proteomics
Munich, Germany
Speaker Selected from Abstract
“High-throughput, multi-platform modelling of cancer metastasis“
7. Systems Medicine in Cancer (SMiC)
Berlin, Germany
Speaker Selected from Abstract
“Network modelling to identify differences in networks between non-metastatic and metastatic tumour states“
2012
6. ICTR-PHE; “Uniting physics, biology and medicine for better healthcare“
Geneva, Switzerland
Invited Speaker
“Remodeling and homeostasis of the extracellular matrix: Implications for fibrotic diseases and cancer“
2011
5. Joint TuMIC-MRS Conference; “New Concepts in Cancer Metastasis“
Lisbon, Portugal
Invited Speaker, AICR Lecture
“The Metastatic Microenvironment: Implications for Lysyl Oxidase in Fibrosis-Enhanced Breast Cancer Metastasis”
More Info
4. Cold Spring Harbor; “The Biology of Cancer: Microenvironment, Metastasis & Therapeutics
“Cold Spring Harbor, New York, USA
Speaker Selected from Abstract
“Fibrosis and the pre-metastatic niche: Implications for Lysyl Oxidase“
2010
3. British Society for Matrix Biology (BSMB): “Inflammation Meets Matrix Biology”
Norwich, United Kingdom
Speaker Selected from Abstract
“Matrix Remodelling and The Pre-Metastatic Niche: Implications for Lysyl Oxidase“
2009
2. Beatson International Cancer Conference: “Microenvironment, Motility and Metastasis“
Glasgow, United Kingdom
AICR Selected Short Talk
“A critical role for lysyl oxidase in pre-metastatic niche formation“
1. Institute of Cancer Research (ICR) Centenary Conference: “From Genes to Drugs”
London, United Kingdom
Speaker selected from Abstract
“Stopping the spread: Lysyl oxidase and the pre-metastatic niche“
Poster Presentations
2017
29th Annual Lorne Cancer Conference
Lorne, VIC, Australia
“ISDoT: In Situ Decellularisation of Tissues for high resolution imaging and proteomic analysis of native extracellular matrix”
2014
British Society for Matrix Biology (BSMB): “Location, Location, Location; the matrix and the microenvironment“
Bristol, United Kingdom
“Biomechanical and biochemical modulation of extracellular matrix properties during colorectal cancer progression“
2013
Beatson International Cancer Conference: “Targeting the Tumour Stroma”
Glasgow, United Kingdom
“The hypoxic secretome reveals lysyl oxidase as a critical mediator of pre-metastatic bone lesions in breast cancer“
2012
Metastasis Research Society (MRS) 14th Biennial Congress
Brisbane, Australia
“Microenvironmental regulation of kinase signalling dynamics as a critical mediator of tumour metastasis“
Integrative Network Biology: “Network Medicine”
Helsingør, Denmark
“Remodelling of the ECM as a critical mediator of tumour metastasis“
British Society for Matrix Biology (BSMB): “Matrix Molecular Biology: Integrator of Tissue Function and Disease“
Oxford, United Kingdom
“Lysyl Oxidase mediates micro-environmental stiffness to drive colorectal cancer progression through FAK“
2011
Beatson International Cancer Conference: “Cancer Models and Novel Therapies”
Glasgow, United Kingdom
“Fibrosis and the pre-metastatic niche: Implications for lysyl oxidase“
2010
UK Adhesion Society: “Get Connected“
Manchester, United Kingdom
“Matrix remodeling and the pre-metastatic niche: Implications for lysyl oxidase“
MetaFight: “Unraveling Cancer Cell Invasion and Metastasis“
Turin, Italy
“Matrix remodeling and the pre-metastatic niche: Implications for lysyl oxidase“
